Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-21
2009-06-09
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S153000, C546S157000
Reexamination Certificate
active
07544803
ABSTRACT:
Compounds having the general structureand compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
REFERENCES:
patent: 5919776 (1999-07-01), Hagmann et al.
patent: 98/09630 (1998-03-01), None
patent: 2000/006146 (2000-02-01), None
patent: 03/068749 (2003-08-01), None
patent: 2004/110986 (2004-12-01), None
Yang, Dalton Trans vol. 17, pp. 3419-3424, 2003.
Cussac, Naunyn-Schmiedeberg's Arch of Pharm, vol. 365(3), pp. 242-252, 2002.
Zhang, BioMetals, vol. 16(3), 485-496, 2003.
Marti, Brit J of PHarm, vol. 138(1), 91-98, 2003.
Balakin, J of Chem Info and Computer Sciences, vol. 43(6), pp. 1332-1342, 2002.
New, CA 138:147807, abstract only of Neurosignals, vol. 11(4), pp. 197-212, 2002.
Hulme Christopher
Ncube Mghele Vellah
Norman Mark H.
Ognyanov Vassil I.
Pettus Liping H.
Amgen Inc.
Person Richard V.
Seaman D. Margaret
LandOfFree
Vanilloid receptor ligands and their use in treatments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vanilloid receptor ligands and their use in treatments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vanilloid receptor ligands and their use in treatments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4074327